FIA
DBTX

FNY Investment Advisers’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

FNY Investment Advisers’s Portfolio DBTX Stock Details DBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,200
Closed -$9K – 974
2022
Q1 		$9K Buy
+3,200
New +$12.3K 0.01% 477

Other funds holding DBTX

TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
HMC
Harvard Management Company Boston, Massachusetts $1.82B AUM 26.23% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

FNY Investment Advisers's DBTX Position: Q2 2022 in Review

FNY Investment Advisers sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q2 2022, closing a stake of 3,200 shares — an estimated $9K sold.

FNY Investment Advisers first reported a position in DBTX in Q1 2022 and held it in 1 quarter. The position peaked at $9K in Q1 2022. 42 funds tracked by Wall St. Rank hold DBTX as of Q2 2022.

  • FNY Investment Advisers reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • FNY Investment Advisers sold 3,200 Decibel Therapeutics, Inc. Common Stock shares in Q2 2022, an estimated $9K.
  • FNY Investment Advisers first reported a position in Decibel Therapeutics, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • FNY Investment Advisers's Decibel Therapeutics, Inc. Common Stock position peaked at $9K in Q1 2022.
  • 42 funds tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q2 2022.

Based on FNY Investment Advisers's 13F filing for Q2 2022, filed 12 Jul 2022.